Bisphosphonate use and subsequent hip fracture in South Korea.
about
Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysisPhysicians' attitudes to contemporary issues on osteoporosis management in KoreaUndertreatment of osteoporosis following hip fractures in jeju cohort study.Risk of hip fractures in men with alpha-blockers: a nationwide study base on claim registry.Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study.Parameters Pointing at an Increased Risk for Contralateral Hip Fractures: Systematic Review.Incidence, Morbidity and Mortality in Patients Older than 50 Years with Second Hip Fracture in a Jeju Cohort Study.Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research DatabaseNational utilization of calcium supplements in patients with osteoporotic hip fracture in Korea.Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry.Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.Subtrochanteric femoral stress fracture with features of atypical femoral fracture in patient with Paget's disease: a case report.Improvement of Osteoporosis Medication after Multimodal Intervention in Patients with Hip Fracture: Prospective Multicenter Study.
P2860
Q26749442-38935B70-2667-42EF-B1C4-622B1FBCD0AFQ33822047-3EDB717F-52E7-41AB-81CA-83095A56BA73Q34627973-B87B8B94-8E28-4770-8878-F515132F6B0EQ35171406-CADB2048-BBC5-4B67-B5D9-4C4E1B3FA430Q35739607-4A52AE6A-3BF9-4AC2-B88E-200DCC7368E3Q36564818-80586E07-3B45-4FF6-ADEB-40EAAB1EFDE8Q37147679-18156719-557B-437C-B28C-FB32D07545F9Q37168515-00779169-C805-46A7-9817-76D434CE426EQ37542738-F321435D-1389-4F7C-AF55-55FE2359412EQ37710327-02F0FA3E-9627-4E27-B7F9-8CCF65829BFBQ39064322-833CD8FA-46D1-4F14-B41F-9E213C2EE898Q40313121-63125212-0001-441F-8489-D3CF776B2EA1Q49465302-F0101460-5F8C-4ABE-9B1E-C35931D798B8Q55288624-A32F9D3C-0009-4767-A85E-6C16395F230F
P2860
Bisphosphonate use and subsequent hip fracture in South Korea.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bisphosphonate use and subsequent hip fracture in South Korea.
@en
type
label
Bisphosphonate use and subsequent hip fracture in South Korea.
@en
prefLabel
Bisphosphonate use and subsequent hip fracture in South Korea.
@en
P2093
P2860
P1476
Bisphosphonate use and subsequent hip fracture in South Korea
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-013-2395-5
P407
P577
2013-05-17T00:00:00Z
P6179
1032394507